Across Surrey Heartlands there’s been a good uptake of innovation products from the NHS Innovation and Technology Tariff and Payment Programme (ITT and ITP) 2017-19.  Launched in partnership with the Academic Health Science Networks, this programme removes the financial barriers to the update of new products which can improve patient care.

Colleagues at Royal Surrey County Hospital have adopted several innovations: Episcissors; angled scissors for use in guided mediolateral episiotomy; SecurAcath to secure peripherally inserted central catheters; HeartFlow; a software product which is used to estimate fractional flow reserve from coronary CT angiography; and Endocuff Vision; improving stability and visualisation during colonoscopy.

At Ashford and St Peter’s Hospitals NHS Foundation Trust, Episcissors have also been adopted, along with Heartflow, Endocuff and Urolift: a prostatic urethral lift system for treatment of benign prostatic enlargement.

The 2019 ITP programme and technical guidance has recently been launched, and includes SpaceOARTM Hydrogel which reduces the side effects for men undergoing radiation treatment for prostate cancer; gammaCore™, a handheld, patient-controlled, non-invasive vagus nerve stimulator used for preventing and treating cluster headaches; and Placental growth factor (PIGF) based testing to help rule out suspected pre-eclampsia and high-sensitivity troponin testing for improved early detection of acute heart attacks. Engagement has begun across Surrey Heartlands to see where these innovations can be introduced to improve care. 

Said Dr Charlotte Roberts, Kent Surrey Sussex AHSN Senior Programme Manager: “The take up of these new innovations has been encouraging and accelerated the partnership work between the AHSN and the Academy. We’ve been delighted to provide support to the teams using them and to ensure they’ve been correctly reimbursed for them. We welcome anyone to get in touch with our team to discuss further.

“We’ve also been having conversations with Surrey Heartlands Cancer, Mental Health, and Women and Children’s programme lead colleagues about their future needs and the many opportunities to join us in innovation activity, which has been very encouraging.”

A revised memorandum of understanding between KSS AHSN and the Academy team is being developed to strengthen areas of focus for our work moving forward. This will concentrate on shared ambitions to accelerate the uptake of well evidenced, high impact innovations based around areas of clinical and operational need at system and locality level.